Genetically targeted radiotherapy of head and neck squamous cell carcinoma using the sodium-iodide symporter (NIS)
- 27 February 2004
- journal article
- Published by Wiley in Head & Neck
- Vol. 26 (3) , 265-271
- https://doi.org/10.1002/hed.10369
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Anion Selectivity by the Sodium Iodide SymporterEndocrinology, 2003
- Adenovirus Biodistribution and Noninvasive Imaging of Gene Expression In Vivo by Positron Emission Tomography Using Human Sodium/Iodide Symporter as Reporter GeneHuman Gene Therapy, 2002
- In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomasGene Therapy, 2002
- In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporterNuclear Medicine and Biology, 2002
- In vivo sodium iodide symporter gene therapy of prostate cancerGene Therapy, 2001
- Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: Effect on clonogenicity in both two-and three-dimensional modelsCancer Gene Therapy, 2000
- A comprehensive study on the blockage of thyroid and gastric uptakes of 188re-perrhenate in endovascular irradiation using liquid-filled balloon to prevent restenosisNuclear Medicine and Biology, 2000
- Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorateNuclear Medicine Communications, 1998
- Cloning of the Human Sodium Iodide SymporterBiochemical and Biophysical Research Communications, 1996
- Cloning and characterization of the thyroid iodide transporterNature, 1996